FNY Investment Advisers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $516K | Buy |
+30,818
| New | +$516K | 0.22% | 117 |
|
|
2022
Q2 | – | Sell |
-100
| Closed | – | – | 872 |
|
|
2022
Q1 | $0 | Sell |
100
-200
| -67% | – | ﹤0.01% | 854 |
|
|
2021
Q4 | $2K | Buy |
+300
| New | +$2K | ﹤0.01% | 429 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$4K | – | 866 |
|
|
2021
Q2 | $4K | Buy |
+500
| New | +$4K | ﹤0.01% | 606 |
|
|
2021
Q1 | – | Sell |
-900
| Closed | -$8K | – | 936 |
|
|
2020
Q4 | $8K | Buy |
+900
| New | +$8K | ﹤0.01% | 584 |
|
|
2020
Q3 | – | Sell |
-50
| Closed | – | – | 574 |
|
|
2020
Q2 | $0 | Buy |
+50
| New | – | ﹤0.01% | 554 |
|
|
2020
Q1 | – | Sell |
-100
| Closed | – | – | 751 |
|
|
2019
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 1002 |
|
|
2019
Q3 | $0 | Buy |
+100
| New | – | ﹤0.01% | 1104 |
|
|
2018
Q4 | – | Sell |
-9,900
| Closed | -$213K | – | 916 |
|
|
2018
Q3 | $213K | Buy |
+9,900
| New | +$213K | 0.05% | 184 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 959 |
|